StockData
Design Therapeutics, Inc. logo

Design Therapeutics, Inc. (DSGN) stock

DSGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$9.84−0.08 (-0.81%)

Close on Nov 17, 2026Market cap $615.80MP/E –Yield –

Design Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Design Therapeutics's market cap was $673.99M on Nov 11, 2026, against $534.89M a year earlier. Over the last 5 years it ranged from $114.20M to $1.18B, with a median of $395.18M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$673.99M+26.1%
2025Dec 31, 2025$534.32M+52.9%
2024Dec 31, 2024$349.35M+135.4%
2023Dec 29, 2023$148.39M-74.1%
2022Dec 30, 2022$572.92M-51.5%
2021Dec 31, 2021$1.18B–

More Design Therapeutics figures

See a number that looks wrong?